Stock CMH CHORDATE MEDICAL HOLDING AB
Add to a list
To use this feature you must be a member
Log inSign up

Financials Chordate Medical Holding AB

Equities

CMH

SE0009495559

Advanced Medical Equipment & Technology

Market Closed - Nasdaq Stockholm
Other stock markets
 16:19:44 24/05/2024 BST 		5-day change 1st Jan Change
0.0492 SEK -1.60% Intraday chart for Chordate Medical Holding AB -10.22% -69.33%
05-24 Chordate Medical Holding AB Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
05-07 Chordate Medical Receives Patent Approval in the US CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 19.38 31.15 52.01 163.2 82.17 37.28
Enterprise Value (EV) 1 23.56 27.59 36.47 134.3 78.49 28.82
P/E ratio -0.44 x -0.9 x -1.48 x -5.45 x -2.89 x -1.23 x
Yield - - - - - -
Capitalization / Revenue 20.5 x 10.6 x 14.4 x 74.8 x 757 x 21.3 x
EV / Revenue 24.9 x 9.36 x 10.1 x 61.5 x 723 x 16.5 x
EV / EBITDA -1.08 x -1.22 x -2.02 x -6.55 x -2.93 x -1.02 x
EV / FCF -2.61 x -2.89 x -2.43 x -9.96 x -5.25 x -1.63 x
FCF Yield -38.3% -34.6% -41.2% -10% -19% -61.4%
Price to Book 1.72 x 2.84 x 2.03 x 4.19 x 7.42 x 2.47 x
Nbr of stocks (in thousands) 15,142 35,399 108,806 157,712 157,712 232,417
Reference price 2 1.280 0.8800 0.4780 1.035 0.5210 0.1604
Announcement Date 04/04/19 27/03/20 19/03/21 25/03/22 30/03/23 12/04/24
1SEK in Million2SEK
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 0.9451 2.949 3.613 2.183 0.1085 1.747
EBITDA 1 -21.77 -22.54 -18.05 -20.5 -26.79 -28.33
EBIT 1 -26.23 -24.54 -19.42 -21.74 -28.02 -29.57
Operating Margin -2,774.99% -832.17% -537.58% -995.84% -25,824.63% -1,692.82%
Earnings before Tax (EBT) 1 -26.69 -24.89 -19.76 -21.77 -27.94 -29.19
Net income 1 -26.69 -24.89 -19.76 -21.77 -27.94 -29.19
Net margin -2,823.52% -843.93% -546.95% -996.98% -25,749.85% -1,670.79%
EPS 2 -2.888 -0.9781 -0.3236 -0.1900 -0.1800 -0.1300
Free Cash Flow 1 -9.016 -9.544 -15.03 -13.48 -14.94 -17.71
FCF margin -953.94% -323.61% -415.94% -617.21% -13,768.02% -1,013.91%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 04/04/19 27/03/20 19/03/21 25/03/22 30/03/23 12/04/24
1SEK in Million2SEK
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 4.18 - - - - -
Net Cash position 1 - 3.56 15.5 29 3.68 8.46
Leverage (Debt/EBITDA) -0.1919 x - - - - -
Free Cash Flow 1 -9.02 -9.54 -15 -13.5 -14.9 -17.7
ROE (net income / shareholders' equity) -181% -224% -108% -67.4% -112% -223%
ROA (Net income/ Total Assets) -65.2% -76.7% -48.5% -36.1% -55.9% -91.1%
Assets 1 40.92 32.43 40.75 60.29 50.02 32.05
Book Value Per Share 2 0.7400 0.3100 0.2400 0.2500 0.0700 0.0600
Cash Flow per Share 2 0.0300 0.1000 0.1400 0.1800 0.0200 0.0400
Capex - - 0.13 - 0.39 0.38
Capex / Sales - - 3.58% - 358.92% 21.65%
Announcement Date 04/04/19 27/03/20 19/03/21 25/03/22 30/03/23 12/04/24
1SEK in Million2SEK
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Advanced Medical Equipment & Technology

1st Jan change Capi.
CHORDATE MEDICAL HOLDING AB Stock Chordate Medical Holding AB
-69.33% 2.26M
THERMO FISHER SCIENTIFIC Stock Thermo Fisher Scientific
+10.03% 223B
DANAHER CORPORATION Stock Danaher Corporation
+13.59% 195B
INTUITIVE SURGICAL, INC. Stock Intuitive Surgical, Inc.
+20.01% 144B
BOSTON SCIENTIFIC CORPORATION Stock Boston Scientific Corporation
+30.83% 111B
SIEMENS HEALTHINEERS AG Stock Siemens Healthineers AG
+2.05% 65.01B
EDWARDS LIFESCIENCES CORPORATION Stock Edwards Lifesciences Corporation
+15.38% 53.02B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. Stock Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
+3.96% 50.45B
AGILENT TECHNOLOGIES, INC. Stock Agilent Technologies, Inc.
+8.37% 44.15B
GE HEALTHCARE TECHNOLOGIES INC. Stock GE HealthCare Technologies Inc.
+3.27% 36.45B
Other Advanced Medical Equipment & Technology
  1. Stock Market
  2. Equities
  3. CMH Stock
  4. Financials Chordate Medical Holding AB